Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,903.50 -9.50 (-0.50%)

Bid:

1,904.00

Ask:

1,905.00

Spread: 1.00 (0.053%)

Market Cap: £76.34b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK and Hengrui unveil development deal worth up to $12bn

(Sharecast News) - GSK has entered into a partnership with Chinese pharmaceutical outfit Hengrui Pharma to jointly develop up to 12 medicines, in a de...

GSK hails EU approval for blood cancer drug as US regulator wavers

(Alliance News) - GSK PLC on Thursday said its Blenrep blood cancer treatment has been approved in Europe, as it awaits a final decision from the US r...

GSK's blood cancer drug gets EU approval

July 24 (Reuters) - The European Union has approved GSK's drug Blenrep to treat relapsed or treatment-resistant forms of a cancer affecting blood pl...

GSK's blood cancer drug gets EU approval for multiple myeloma

July 24 (Reuters) - British drugmaker GSK said on Thursday the European Union has approved the company's blood cancer drug Blenrep for the treatment o...

FTSE 100 notches record close on US-EU trade deal optimism, earnings boost

FTSE 100 up 0.9%, FTSE 250 up 0.6% *

FTSE 100 hits record high on positive corporate news

FTSE 100 up 1%, FTSE 250 up 0.7% *

GSK says US FDA extends review period for Blenrep BLA until October

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has extended the review period for Blenrep combinations in relapsed/refr...

FTSE 100 closes at record high as investors assess earnings and US-Japan trade deal

FTSE 100 up 0.4%, FTSE 250 up 0.4% *